Skip to content
BHP

Enthesis

The fibrocartilaginous insertion of tendon or ligament into bone — the anatomical zone where most repair failures occur.

For laboratory and research use only — not for human consumption.

The enthesis is the specialised interface where a tendon or ligament inserts onto bone, structurally organised as four graded zones: dense fibrous connective tissue, uncalcified fibrocartilage, calcified fibrocartilage, and underlying bone. This graded architecture transmits mechanical load smoothly between tissues of widely differing stiffness and is uniquely difficult to regenerate after injury or surgical repair. Most enthesis sites are intrinsically hypovascular at the fibrocartilaginous transition, which contributes to the slow healing and high re-tear rates observed after rotator cuff, Achilles, ACL, and other tendon-to-bone repairs. The histological hallmark of failed enthesis healing is loss of the gradient organisation, with disorganised scar tissue rather than re-formation of the four-zone structure. Enthesopathy — pathological change at the enthesis — is a recognised feature of seronegative spondyloarthropathies (psoriatic arthritis, ankylosing spondylitis), of overuse injuries (lateral epicondylitis, plantar fasciitis), and of chronic tendinopathy in general. In peptide research, the enthesis is the principal anatomical challenge that drives interest in BPC-157, TB-500, and thymosin beta-4 — compounds proposed to support angiogenesis, tenocyte migration, and organised matrix deposition specifically at this poorly vascularised transition zone.

Related research peptides

Related glossary terms